Q&A: ADHD Expert Offers Clinical Guidance on Prescribing Stimulants

APSARD Board Member, Anthony Rostain, M.A., M.D., was interviewed by Healio Psychiatry. Please see below for the introduction and the link to the full article.

CLICK HERE TO ACCESS THE FULL INTERVIEW

“ADHD is marked by a pattern of inattention and/or hyperactivity-impulsivity that affects daily functioning. According to data from the National Comorbidity Survey Replication, the overall prevalence of adult ADHD in the U.S. is 4.4%, and the estimated lifetime prevalence among those aged 18 to 44 years is 8.1%.

Diagnosing, and subsequently treating, adult ADHD requires a multifaceted approach that includes a thorough evaluation, consideration of cooccurring conditions, patient education and weighing of risks and benefits of treatment with stimulants on a case-by-case basis.

Healio Psychiatry spoke with Anthony L. Rostain, MD, professor of psychiatry at the Hospital of the University of Pennsylvania and the Children’s Hospital of Philadelphia, for clinical guidance on the who, what, when and how of prescribing stimulants. – by Stacey Adams”

Share this with your colleagues...Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
No comments yet.


Leave a Comment


Join today or login to comment on the blog